Delivery Order SPE2DB22D3016-SPE2DB24FASF0
Award Date 4/10/24
Potential Completion Date 4/11/24
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $2,011.38, is for the supply of LOESTRIN 21 1-20 TABLET 21S, a brand name medication. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA, which serves as the primary vehicle for the company to provide pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of pharmaceutical products, specifically the drug Loestrin 21 1-20 tablet. The contract has a ceiling value of $4,677.06 and an ultimate completion date of August 13, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is part...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Loestrin Fe 1-20 tablets. The order has a firm fixed price of $3,332.23 and a completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the delivery of pharmaceutical products. The contract is for the supply of 4,568,504,404 units of LO LOESTRIN FE 1-10 TABLET 28S, with a total ceiling value of $12,719.85. The contract is a firm fixed-price contract with a completion date of June 11, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider based...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,756.95 delivery order contract is for the supply of 4568711234 - LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 7, 2025. This contract is not set aside and is open to all eligible vendors. AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,767.46 firm fixed-price delivery order is for the supply of LOESTRIN 21 1-20 tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for the company to provide a comprehensive range...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The award, valued at $1,799.13, is for the delivery of Loestrin 21 1-20 tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, that serves as the primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LO LOESTRIN FE 1-10 TABLET 28S. The contract has a ceiling value of $15,763.05 and runs through January 7, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB20D1050 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4564147554 LOESTRIN 21 1-20 TABLET 21S. The firm fixed price contract has a ceiling value of $1,231.58 and a period of performance through April 3, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,844.31 firm fixed price delivery order is for the pharmaceutical product LOESTRIN 21 1-20 TABLET 21S. The delivery order was awarded under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FASF0Delivery Order
This firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,037.45 and an ultimate completion date of April 11, 2024. It is for the delivery of LOESTRIN 21 1-20 tablets. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to support Department of Defense medical facilities worldwide. This delivery order does not have a set-aside designation.
Generated 7/10/24, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/10/24 |